Special Issue "Immune Response to the Vaccines against Foot-and-Mouth Disease and Other Similar Animal Diseases"
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 2586
Interests: FMDV; virology; vaccines; animal health; molecular biology; FAST diseases; immunology; monoclonal antibodies; diagnostic methods
Interests: virology; FMD; FAST diseases; emerging diseases; animal health; wildlife; epidemiology
Foot-and-mouth disease (FMD) and other similar animal diseases are still threatening worldwide animal health due to their frequent and inter-regional incursions that have not always been effectively contained. FMD remains one of the most economically important infectious diseases of livestock animals and, together with other similar diseases, is responsible for huge economic losses to the endemic countries.
FMDV is constantly changing. Despite its classification into six different serotypes circulating in many developing countries, there is extensive diversity within each serotype.
At present, vaccination remains the most powerful tool to contain this and other similar diseases, to prevent their circulation and to reduce the mutational possibilities of the involved viruses. For example, vaccination has been used successfully to eradicate FMD from Europe and North America.
Because of the high mutation rate of FMDV and other similar viruses, vaccines need to be continuously improved and tailored to the specific strains causing an outbreak. Numerous issues may compromise the efficacy of currently used vaccines, such as the dangerous large-scale amplification of the virus to be inactivated for vaccine production, the limited duration of immunity induced by the vaccine administration, the possibility of the development of carriers even between vaccinated animals and the need for an efficient cold chain.
In this Special Issue, all papers that gather knowledge on some of the yet-unanswered questions regarding the immune response of animals to vaccination, the mechanisms able to enhance immunity, the in-field evaluation of newly developed vaccines and the new technologies improved to produce new generations of vaccines are welcome. Studies that clarify the relationship between FMDV and other similar viruses and host immune responses are also welcome.
We are sincerely looking forward to hearing back from all interested scientists.
Dr. Efrem Alessandro Foglia
Dr. Tiziana Trogu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- immune response
- FAST disease
- viral animal diseases